Chronic dialysis in children

Principles and Practice of Dialysis

Volumn , Issue , 2012, Pages 613-640

  Warady, Bradley A ^a,b   Jabs, Kathy ^c,d   Goldstein, Stuart L ^e,f  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973098841     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (364)

1. U.S. Renal Data System. USRDS 2007 annual report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
2. Hoffman J. Congenital heart disease. Pediatr Clin North Am 1990;37:25-44.
3. Poplack D. Acute lymphoblastic leukemia. In: Pizzo P, Poplack D, eds. Principles and practice of pediatric oncology. New York: JB Lippincott Co, 1989:323.
4. U.S. Renal Data System. USRDS 2006 annual data report: atlas of end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006.
5. Alexander S, Honda M. Continuous peritoneal diaysis for children: a decade of worldwide growth and development. Kidney Int 1993;43:S65-S74.
6. Warady B, Hebert D, Sullivan E, et al. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997;11:49-64.
7. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). 2007 Annual report 2007.
8. Wiggelinkhuizen J. Peritoneal dialysis in children. S Afr Med J 1971;45:1047-1054.
9. Putiloff, PV. Materials for the study of the laws of growth of the human body in relation to the surface areas of different systems: the trial on Russian subjects of planigraphic anatomy as a means for exact anthropometry; one of the problems of anthropology. Report of Dr. P.V. Putiloff at the meeting of the Siberian Branch of the Russian Geographic Society, 1884.
10. Wegner G. Chirurgische Bemerkungen umlautuber die peritoneal Humlautohle, mit besonder Berucksichtigung der Ovariotomie. Arch Klin Chir 1887;20:51.
11. Esperanca M, et al. Peritoneal dialysis efficiency in relation to body weight. J Pediatr Surg 1966;1:162-169.
12. Gruskin A, et al. Developmental aspects of peritoneal dialysis kinetics. In: Fine R, ed. Chronic ambulatory peritoneal dialysis (CAPD) and chronic cycling peritoneal dialysis. Boston: Martinus Nijhoff, 1987:33-46.
13. Kohaut E. Effects of dialysate volume on ultrafiltration in young patients treated with CAPD. Int J Pediatr Nephrol 1986;7:13-16.
14. Schaefer F, Haraldsson B, Haas S, et al. Estimation of peritoneal mass transport by three-pore model in children. Kidney Int 1998;54:1372-1379.
15. Fischbach M, et al. Dynamic changes of the total pore area available for peritoneal exchange in children. J Am Soc Nephrol 2001;12:1524-1529.
16. Rippe B, Stelin G. Simulations of peritoneal transport during CAPD. Kidney Int 1989;35:1234-1244.
17. Nolph K. Peritoneal anatomy and transport physiology. In: Drukker W, et al., eds. Replacement of renal function by dialysis. Boston: Martinus Nijhoff, 1983:440-456.
18. Mactier R, et al. Role of peritoneal cavity lymphatic absorption in peritoneal dialysis. Kidney Int 1987;32:65-72.
19. Haraldsson B. Assessing the peritoneal dialysis capacities of individual patients. Kidney Int 1995;47:1187-1198.
20. Morgenstern B, Pyle W, Gurskin A, et al. Transport characteristics of the pediatric peritoneal membrane. Kidney Int 1984;25:259-264.
21. Geary D, Harvey E, Balfe J. Mass transfer area coefficients in children. Perit Dial Int 1994;14:30-33.
22. Warady B, Alexander S, Hossli S, et al. Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol 1996;7:2385-2391.
23. Bouts A, et al. Standard peritoneal permeability analysis in children. J Am Soc Nephrol 2000;11:943-950.
24. Morgenstern B. Equilibration testing: close but not quite right. Pediatr Nephrol 1993;7:290-291.
25. Kohaut E, Waldo F, Benfield M. The effect of changes in dialysate volume on glucose and urea equilibration. Perit Dial Int 1994;14:236-239.
26. de Boer A, van Schaijk T, Willems H, et al. The necessity of adjusting dialysate volume to body surface area in pediatric peritoneal equilibration tests. Perit Dial Int 1997;17:199-202.
27. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991;40:315-325.
28. Rippe B. A three-pore model of peritoneal transport. Perit Dial Int 1991;13:S35-S38.
29. Pyle, WK. Mass transfer in peritoneal dialysis. PhD dissertation. 1987. Austin, University of Texas.
30. Kohaut E, Alexander S. Ultrafiltration in the young patient on CAPD. In: Moncrief J, Popovich R, eds. CAPD update. New York: Masson, 1981:221-226.
31. Balfe J, Hanning R, Vigneux A. A comparison of peritoneal water and solute movement in younger and older children on CAPD. In: Fine R, Schaefer F, Mehls O, eds. CAPD in children. New York: Springer-Verlag New York, 1985:14-19.
32. Schaefer F, Fischbach M, Heckert K. Hydrostatic intraperitoneal pressure in children on peritoneal dialysis. Perit Dial Int 1996;16:S79.
33. Mactier R, Khanna R, Moore H, et al. Kinetics of peritoneal dialysis in children: role of lymphatics. Kidney Int 1988;34:82-88.
34. Schr'der C, Reddingius R, van Dreumel J, et al. Transcapillary ultrafiltration and lymphatic absorption during childhood continuous ambulatory peritoneal dialysis (CAPD). Nephrol Dial Transplant 1991;6:571-573.
35. Kaiser B, Potter D, Bryant R, et al. Acid-base changes and acetate metabolism during routine and high-efficiency hemodialysis in children. Kidney Int 1981;19:70-79.
36. Schoumacher R, Chevalier R, Gomez R, et al. Enhanced clearance of vancomycin by hemodialysis in a child. Pediatr Nephrol 1989; 3:83-85.
37. Hakim R, Fearon D, Lazarus J. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984; 26:194-200.
38. Zaoui P, Stone W, Hakim R. Effects of dialysis membranes on -2-microglobulin production and cellular expression. Kidney Int 1990;38:962-968.
39. Goldstein S, Currier H, Graf C, et al. Outcome in children receiving continuous veno-venous hemofiltration. Pediatrics 2001; 107:1309-1312.
40. Gillespie R, Seidel K, Symons J. Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol 2004;19:1394-1399.
41. Foland J, Fortenberry J, Warshaw B, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 2004;32:1771-1776.
42. Goldstein S, Somers M, Baum M, et al. Pediatric patients with multi-organ system dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005;67:653-658.
43. Strazdins V, Watson A, Harvey B. European Pediatric Peritoneal Dialysis Working Group. Renal replacement therapy for acute renal failurein children: European guidelines. Pediatr Nephrol 2004;19: 199-207.
44. Anochie I, Eke F. Acute renal failure in Nigerian children: Port Harcourt experience. Pediatr Nephrol 2005;20:1610-1614.
45. Bunchman T, McBryde K, Mottes T, et al. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol 2001;16: 1067-1071.
46. Flynn J, Kershaw D, Smoyer W, et al. Peritoneal dialysis for management of pediatric acute renal failure. Perit Dial Int 2001;21:390-394.
47. Warady B, Bunchman T. Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 2000;15:11-13.
48. Goldstein S. Overview of pediatric renal replacement therapy in acute renal failure. Artif Organs 2003;27:781-785.
49. Bunchman T, Donckerwolcke R. Continuous arterial-venous diahe-mofiltration and continuous veno-venous diahemofiltration in infants and children. Pediatr Nephrol 1994;8:96-102.
50. Mahoney C, Arieff A. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis 1982;2:324-336.
51. Bereket G, Fine R. Pediatric renal transplantation. Pediatr Clin North Am 1995;42:1603-1628.
52. Fine R. Renal transplantation for children-the only realistic choice. Kidney Int 1985;17:S15-S17.
53. Goldstein S. Advances in renal replacement therapy as a bridge to renal transplantation. Pediatr Transplant 2007;11:463-470.
54. Furth S, Hwang W, Yang C, et al. Relation between pediatric experience and treatment recommendations for children and adolescents wtih kidney failure. JAMA 2001;285:1027-1033.
55. Neu A, Ho P, McDonald R, et al. Chronic dialysis in children and adolescents. The 2001 NAPRTCS annual report. Pediatr Nephrol 2002;17:656-663.
56. Baum M, Powell D, Calvin S, et al. Continuous ambulatory peritoneal dialysis in children: comparison with hemodialysis. N Engl J Med 1982;307:1537-1542.
57. Geary D, Piva E, Tyrrell J, et al. Home nocturnal hemodialysis in children. J Pediatr 2005;147:383-387.
58. Fischbach M, Terzic J, Menouer S, et al. Intensified and daily hemodialysis in children might improve statural growth. Pediatr Nephrol 2006;21:1746-1652.
59. Warady B, Fischbach M, Geary D, et al. Frequent hemodialysis in children. Adv Chronic Kidney Dis 2007;14:297-303.
60. Palmer R, Quinton W, Gray J. Prolonged peritoneal dialysis for chronic renal failure. Lancet 1964;1:700-702.
61. Palmer R, Newell J, Gray J, et al. Treatment of chronic renal failure by prolonged peritoneal dialysis. N Engl J Med 1966;274:248-254.
62. Tenckhoff H, Schechter H. A bacteriologically safe peritoneal access device. Trans Am Soc Artif intern Organs 1966;14:181-186.
63. Boen S, Mion C, Curtis F, et al. Periodic peritoneal dialysis using the repeated puncture technique and an automated cycling machine. Trans Am Soc Artif intern Organs 1964;10:409-414.
64. Tenckhoff H, Meston B, Shilipetar G. A simplified automatic peritoneal dialysis system. Trans Am Soc Artif intern Organs 1972; 18:436-440.
65. Counts S, Hickman R, Garbaccio A, et al. Chronic home peritoneal dialysis in children. Trans Am Soc Artif intern Organs 1973;19:157-163.
66. Hickman R. Nine years experience with chronic peritoneal dialysis in childhood. Dial Transplant 1978;7:803.
67. Brouhard B, Berger M, Cunningham R, et al. Home peritoneal dialysis in children. Trans Am Soc Artif intern Organs 1979;25:90-94.
68. Baluarte HJ, Grossman MS, Polinsky MD, et al. Experience with intermittent home peritoneal dialysis (IHPD) in children. Pediatr Res 1980;14:994.
69. Lorentz WB, Hamilton RW, Disher B, etal. Home peritoneal dialysis during infancy. Clin Nephrol 1981;15(4):194-197.
70. Potter D, McDaid T, Ramirez J, et al. Peritoneal dialysis in children. In: Atkins R, Thomson N, Farrell P, eds. Peritoneal dialysis. NewYork: Churchill Livingstone, 1981:356-361.
71. Popovich R, Moncrief J, Dechered J, et al. The definition of a novel wearable/portable equilibrium dialysis technique. Trans Am Soc Artif Intern Organs 1976;5:64.
72. Balfe J, Irwin M. Continuous ambulatory peritoneal dialysis in children. In: Legrain M, ed. Continuous ambulatory peritoneal dialysis. Amsterdam: Excerpta Medica, 1980:131-136.
73. Oreopoulos D, Katirtzoglou A, Arbus G, et al. Dialysis and transplantation in young children. Br Med J 1979;16:1628-1629.
74. Kohaut E. Continuous ambulatory peritoneal dialysis: a preliminary pediatric experience. Am J Dis Child 1981;135:270-271.
75. Eastham E, Kirplani H, Francis D, et al. Pediatric continuous ambulatory peritoneal dialysis. Arch Dis Child 1982;57:677-680.
76. Guillot M, et al. Advances in peritoneal dialysis. In: Gahl G, et al., ed. Amsterdam: Excerpta Medica, 1981:203-207.
77. Price C, Suki W. Newer modifications of peritoneal dialysis: options in the treatment of patients with renal failure. Am J Nephrol 1980; 1:97-104.
78. Von Lilien T, et al. Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children. J Pediatr 1987;111:513-518.
79. Fine R, Ho M. The role of APD in the management of pediatric patients: a report of the North American Pediatric Renal Transplant Cooperative Study. Semin Dial 2002;15:427-429.
80. Verrina E, Edefonti A, Gianoglio B, et al. A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr Nephrol 2004;19:82-90.
81. Twardowski Z, Nolph K, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull 1986;7:138-147.
82. Warady B, Andrews W. Peritoneal dialysis access. In: Geary D, Schaefer F, eds. Comprehensive clinical nephrology. Philadelphia: Elsevier Science, 2008.
83. Sieniawska M, Roszkowska-Blaim M, Warchol S. Preliminary results with the swan neck presternal catheter for CAPD in children. Adv Perit Dial 1993;9:321-324.
84. Twardowski Z, et al. Four-year experience with swan neck presternal peritoneal dialysis catheter. Am J Kidney Dis 1996;27:99-105.
85. Chadha V, Jones L, Ramirez Z, et al. Chest wall peritoneal dialysis catheter placement in infants with a colostomy. Adv Perit Dial 2000;16:318-320.
86. Warchol S, Roszkowska-Blaim M, Sieniawska M. Swanneckpresternal peritoneal dialysis catheter: five-year experience in children. Perit Dial Int 1998;18:187.
87. Warchol S, Ziolkowska H, Roszkowska-Blaim M. Exit-site infection in children on peritoneal dialysis: comparison of two types ofperitoneal catheters. Perit Dial Int 2003;23:169-173.
88. Yerram P, Gill A, Prowant B, et al. A 9-year survival analysis of the presternal Missouri swan-neck catheter. Adv Perit Dial 2007; 23:90-93.
89. Lerner G, Warady B, Sullivan E, et al. Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1999;13:404-417.
90. Rinaldi S, Sera F, Verrina E, et al. Chronic peritoneal dialysis catheters in children: a fifteen-year experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis. Perit Dial Int 2004;24:481-486.
91. Neu A, Kohaut E, Warady B. Current approach to peritoneal access in North American children: a report of the Pediatric Peritoneal Dialysis Study Consortium. Adv Perit Dial 1995;11:289-292.
92. Reissman P, Lyass S, Shiloni E, etal. Placement of a peritoneal dialysis catheter with routine omentectomy: does it prevent obstruction of the catheter? Eur J Surg 1998;164:703-707.
93. Pumford N, Cassey J, Uttley W. Omentectomy with peritoneal catheter placement in acute renal failure. Nephron 1994;68:327-328.
94. Strippoli G, Tong A, Johnson D, et al. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients [review]. Cochrane Database Syst Rev 2007:2.
95. Strippoli G, Tong A, Johnson D, et al. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2005:2.
96. Gokal R, Alexander S, Ash S, et al. Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. (Official report from the International Society for Peritoneal Dialysis). Perit Dial Int 1998;18:11-33.
97. Kimberly K, Washburn K, Currier H, et al. Surgical technique for peritoneal dialysis catheter placement in the pediatric patient: a North American survey. Adv Perit Dial 2004;20:218-221.
98. Daschner M, Gfrorer S, Zachariou Z, et al. Laparoscopic tenckhoff cathter implantation in children. Perit Dial Int 2002;22:22-26.
99. Flanigan M, Gokal R. Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments. Perit Dial Int 2005;25:132-139.
100. Katyal A, Mahale A, Khanna R. Antibiotic prophylaxis before peritoneal dialysis catheter insertion. Adv Perit Dial 2002;18:112-115.
101. Warady B, Sullivan E, Alexander S. Lessons from the peritoneal dialysis patient database: a report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int 1996;49:S68-S71.
102. Golper T, et al. Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Am J Kidney Dis 1996;28:428-436.
103. Warady B, Alexander S, Watkins S, et al. Optimal care of the pediatric end-stage renal disease patient on dialysis. Am J Kidney Dis 1999;33:567-583.
104. Sliman G, Klee K, Gall-Holden B, et al. Peritoneal equilibration test curves and adequacy of dialysis in children on automated peritoneal dialysis. Am J Kidney Dis 1994;24:813-818.
105. Schaefer F, Langenbeck D, Heckert K, et al. Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children. Adv Perit Dial 1992;8:410-415.
106. Warady B, Jennings J. The short PET in pediatrics. Perit Dial Int 2007;27:441-445.
107. Warady B. The peritoneal equilibration test (PET) in pediatrics. Contemp Dial nephrol 1994:21-41.
108. Blake J, Burkart J, Churchill D. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996;16:448-456.
109. National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for 2006 updates. Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 2006; 48:S1-S322.
110. Rocco M, et al. Changes in peritoneal transport during the first month of peritoneal dialysis. Perit Dial Int 1995;15:12-17.
111. Rocco M. Body surface area limitations in achieving adequate therapy in peritoneal dialysis patients. Perit Dial Int 1996;16:617-622.
112. Johnson D, Mudge D, Blizzard S, et al. A comparison of peritoneal equilibration tests performed 1 and 4 weeks after PD commencement. Perit Dial Int 2004;24:460-465.
113. Schaefer F, Klaus G, Mehls O. Peritoneal transport properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dilaysis. Mid-European Pediatric Peritoneal Dialysis Study Group. J Am Soc Nephrol 1999;10:1786-1792.
114. Fried L. Higher membrane permeability predicts poorer patient survival. Perit Dial Int 1997;17:387-388.
115. Churchill D, Thorpe K, Nolph K, et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998;9:1285-1292.
116. Kagan A, et al. Role of peritoneal loss of albumin in the hypoalbuminemia of continuous ambulatory peritoenal dialysis patients: relationship to peritoneal transport of solutes. Nephrology 1995;71:314-320.
117. Ronnholm K, Holmberg C. Peritoneal dialysis in infants. Pediatr Nephrol 2006;21:751-756.
118. White C, Gowrishankar M, Feber J, et al. Canadian Association of Pediatric Nephrologists (CAPN) and Peritoneal Dialysis Working Group. Clinical practice guidelines for pediatric peritoneal dialysis. Pediatr Nephrol 2006; 21:1059-1066.
119. Burkart J, Schreiber M, Korbet S, et al. Solute clearance approach to adequacy of peritoneal dialysis. Perit Dial Int 1996;16:457-470.
120. Fischbach M, et al. Impact of fill volume changes on peritoneal dialysis tolerance and effectiveness in children. Adv Perit Dial 1996;16:321-323.
121. Fischbach M, et al. Optimal volume prescription for children on peritoneal dialysis. Perit Dial Int 2000;20:603-606.
122. Rusthoven E, van der Vlugt M, van Lingen-van Bueren L, et al. Evaluation of intraperitoneal pressure and the effect of different osmotic agents on intraperitoneal pressure in children. Perit Dial Int 2005;25:352-356.
123. Fischbach M, Terzic J, Becmeur F, et al. Relationship between intraperitoneal hydrostatic pressure and dialysate volume in children on PD. Adv Perit Dial 1996;12:330-334.
124. Fischbach M, Terzic J, Laugel V, et al. Measurement of hydrostatic intraperitoneal pressure: a useful tool for the improvement of dialysis dose prescription. Pediatr Nephrol 2003;18:976-980.
125. Fischbach M, Terzic J, Provot E, et al. Intraperitoneal pressure in children: fill-volume related and impacted by body mass index. Perit Dial Int 2003;23:391-394.
126. Warady B, Watkins S, Fivush B, et al. Validation of PD Adequest 2.0 for pediatric dialysis patients. Pediatr Nephrol 2001;16:205-211.
127. Verrina E, Amici G, Perfumo F, et al. The use of the PD Adequest mathematical model in pediatric patients on chronic peritoneal dialysis. Perit Dial Int 1998;18:322-328.
128. Fischbach M, Terzic J, Menouer S, et al. Effects of automated peritoneal dialysis on residual daily urinary volume in children. Adv Perit Dial 2001;17:269-273.
129. Feber J, Scharer K, Schaefer F, et al. Residual renal function in children on haemodialysis and peritoneal dialysis. Pediatr Nephrol 1994;8:579-583.
130. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.
131. Lutes R, Perlmutter J, Holley J, et al. Loss of residual renal function in patients on peritoneal dialysis. Adv Perit Dial 1993;9:165-168.
132. Li P, Chow K, Wong T, et al. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 2003;139:105-112.
133. Suzuki H, Kanno Y, Sugahara S, et al. Effects of an angiotensin II receptor blocker, calsartan, on residual renal function in patients on CAPD. Am J Kidney Dis 2004;43:1056-1064.
134. Phakdeekitcharoen B, Leelasa-nguan P. Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients. Am J Kidney Dis 2004;44:738-746.
135. Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal diaysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-1320.
136. Lo W, Lui S, Chan T, et al. Minimal and optimal peritoneal Kt/V targets: results of an anuric peritoneal dialysis patient's survival analysis. Kidney Int 2005;67:2032-2038.
137. Lo W, Bargman J, Burkart J, et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int 2006;26:520-522.
138. Holtta T, Ronnholm K, Jalanko H, et al. Clinical outcome of pediatric patients on peritoneal dialysis under adequacy control. Pediatr Nephrol 2000;14:889-897.
139. McCauley L, et al. Enhanced growth in children on peritoneal dialysis (PD): dialysis dose, nutrition, and metabolic control. Perit Dial Int 2000;20:S89.
140. Champoux S, etal. Enhanced response to growth hormone in children on peritoneal dialysis. Perit Dial Int 2001;21:S86.
141. Chadha V, Blowey D, Warady B. Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis? Perit Dial Int 2001;21:S179-S184.
142. van der Voort J, et al. Can the DOQI guidelines be met by peritoneal dialysis alone in pediatric patients? Pediatr Nephrol 2000; 14:717-719.
143. Chadha V, et al. What are the clinical correlates of adequate peritoneal dialysis? Pediatr Nephrol 2001;21:480-489.
144. Centers for Medicare Medicaid Services. Annual report, end stage renal disease clinical performance measures project. Baltimore, Maryland: Department of Health and Human Services, Centers for Medicare Medicaid Services, Office of Clinical Standards Quality, 2005.
145. Wuhl E, Fusch C, Schörer K, et al. Assessment of total body water in paediatric patients on dialysis. Nephrol Dial Transplant 1996;11:75-80.
146. Morgenstern B, Nair K, Lerner G, et al. Impact of total body water errors on Kt/V estimates in children on peritoneal dialysis. Adv Perit Dial 2001;17:260-263.
147. Mendley S, Majkowski N, Schoeller D. Validation of estimates of total bodywater in pediatric dialysis patients by deuterium dilution. Kidney Int 2005;67:2056-2062.
148. Mellits D, Cheek D. The assessment of body water and fatness from infancy to adulthood. Monogr Soc Res Child Dev 1970;35:12-26.
149. Morgenstern B, Mahoney D, Warady B. Estimating total body water in children on the basis of height and weight: are evaluation of the formulas of Mellits and Cheek. J Am Soc Nephrol 2002;13:1884-1888.
150. Morgenstern B, Wuhl E, Sreekumaran Nair K, et al. Anthropometric prediction of total body water in children who are on pediatric peritoneal dialysis. J Am Soc Nephrol 2006;17:285-293.
151. Gehan E, George S. Estimation of human body surface area from height and weight. Cancer Chemother Rep 1970;54:225.
152. Heimburger O, Stenvinkel P, Berglund L, et al. Increased plasma lipoprotein (a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Nephron 1996;72: 135-144.
153. Fusshoeller A, Plail M, Grabensee B, et al. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant 2004;19:2101-2106.
154. Schmitt C, von Heyl D, Rieger S, et al. Reduced systemic advanced glycation endproducts in children receiving peritoneal dialysis with low glucose degradation product content. Nephrol Dial Transplant 2007;22:2038-2044.
155. McIntyre C. Update on peritoneal dialysis solutions. Kidney Int 2007;71:486-490.
156. Canepa A, et al. Nutritional status in children receiving chronic peritoneal dialysis. Perit Dial Int 1996;16:S526-S531.
157. Salusky I, Fine R, Nelson P, et al. Nutritional status of children undergoing continuous peritoneal dialysis. Am J Clin Nutr 1983;38:599-611.
158. Scolnik D, Balfe J. Initial hypoalbuminemia and hyperlipidemia persist during chronic peritoneal dialysis in children. Perit Dial Int 1993;13:136-139.
159. Ruley E, et al. Feeding disorders and gastroesophageal reflux in infants with chronic renal failure. Pediatr Nephrol 1989;3:424-429.
160. National Kidney Foundation. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000;35(Suppl 2):S1-S140.
161. National Research Council. Recommended dietary allowances. Washington, DC: National Academy Press, 1989:1-284.
162. Balfe J, Vigneux A, Willumsen J, et al. The use of CAPD in the treatment of children with end-stage renal disease. Perit Dial Bull 1981;1:35-38.
163. Edefonti A, Paglialonga F, Picca M, et al. A prospective multicentre study of the nutritional status in children on chronic peritoneal dialysis. Nephrol Dial Transplant 2006;21:1946-1951.
164. Drachman R, et al. Protein losses during peritoneal dialysis in children. In: Fine R, et al., eds. CAPD in children. New York: Springer-Verlag New York, 1985:78-83.
165. Kopanati S, Baum M. Peritoneal protein losses in children with steriod-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis. Pediatr Nephrol 2006;21:1013-1019.
166. Quan A, Baum M. Protein losses in children on continuous cycler peritoneal dialysis. Pediatr Nephrol 1996;10:728-731.
167. Wassner S, Abitbol C, Alexander S, et al. Nutritional requirements for infants with renal failure. Am J Kidney Dis 1986;7:300-305.
168. Cano F, Azocar M, Delucchi M, et al. Nitrogen balance studies and Kt/V urea in children undergoing chronic peritoneal dialysis. Adv Perit Dial 2004;20:245-250.
169. Meireles C, Price S, Pereira A, et al. Nutrition and chronic renal failure in rats: what is an optimal dietary protein? J Am Soc Nephrol 1999;10:2367-2373.
170. Balfe J. Intraperitoneal amino acids in children receiving chronic peritoneal dialysis. Perit Dial Int 1996;16:S515-S516.
171. Taylor G, Patel V, Spencer S, et al. Long-term use of 1.1% amino acid dialysis solution in hypoalbuminemic continuous ambulatory peritoneal dialysis patients. Clin Nephrol 2002;58:445-450.
172. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 2005;46(Suppl 1):S1-S121.
173. Warady B, Kriley M, Alon U, et al. Vitamin status of infants receiving long-term peritoneal dialysis. Pediatr Nephrol 1994;8:354-356.
174. Kriley M, Warady B. Vitamin status of pediatric patients recieving long-term peritoneal dialysis. Am J Clin Nutr 1991;53:1476-1479.
175. Pereira A, Hamani N, Nogueira P, etal. Oral vitaminin take in children receiving long-term dialysis. J Ren Nutr 2000;10:24-29.
176. Parrott K, et al. Plasma vitamin A levels in children on CAPD. Perit Dial Bull 1987;7:90-92.
177. Warady B, Borum P, Stall C, et al. Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis. Am J Nephrol 1990;10:109-114.
178. Murakami R, Momota T, Yoshiya K, et al. Serum carnitine and nutritional status in children treated with continuous ambulatory peritoneal dialysis. J Pediatr Gastroenterol 1990;11:371-374.
179. Belay B, Esteban-Cruciani N, Walsh C, et al. The use of levocarnitine in children with renal disease: a review and a call for future studies. Pediatr Nephrol 2006;21:308-317.
180. Tamura T, Vaughn W, Waldo F, et al. Zinc and copper balance in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol 1989;3:309-313.
181. Zlotkin S, Rundle M, Hanning R, et al. Zinc absorption from the glucose and amino acid dialysates in children on continuous ambulatory peritoneal dialysis (CAPD). J Am Coll Nutr 1987;6:345-350.
182. Warady B, Weis L, Johnson L. Nasogastric tube feeding in infants on peritoneal dialysis. Perit Dial Int 1996;16:S521-S525.
183. Geary D, et al. Tube feeding in infants on peritoneal dialysis. Perit Dial Int 1996;16:S517-S520.
184. Coleman J, et al. The optimal route for nutritional support of children with chronic renal failure. Perit Dial Int 1996;16:S517-S520.
185. Levin L, Balfe J, Geary D, et al. Gastrostomy tube feeding in children on CAPD. Perit Dial Bull 1987;7:223-226.
186. Balfe J, Secker D, Coulter P, et al. Tube feeding in children on chronic peritoneal dialysis. Adv Perit Dial 1990;6:257-261.
187. O'Regan S, Garel L. Percutaneous gastrojejunostomy for caloric supplementation in children on peritoneal dialysis. Adv Perit Dial 1990;6:273-275.
188. Warady B, Kriley M, Belden B, etal. Nutritional and behavioral aspects of nasogastric tube feedings in infants receiving chronic peritoneal dialysis. Adv Perit Dial 1990;6:265-268.
189. Wood E, Bunchman T, Khurana R, et al. Complications of nasogastric and gastrostomy tube feeding in infants receiving chronic peritoneal dialysis. Adv Perit Dial 1990;6:162-164.
190. Brewer E. Growth of small children managed with chronic peritoneal dialysis and nasogastric tube feedings: 203 months experience in 14 patients. Adv Perit Dial 1990;6:269-272.
191. Kamen R. Impaired development of oral-motor functions required for normal oral feeding as a consequence of tube feeding during infancy. Adv Perit Dial 1990;6:276-278.
192. Lapeyraque A, Haddad E, Andre J, et al. Sudden blindness caused by anterior ischemic optic neuropathy in 5 children on continuous peritoneal dialysis. Am J Kidney Dis 2003;42:E3-E9.
193. Roodhooft A, Van Hoeck K, Van Acker K. Hypophosphatemia in infants on continuous ambulatory peritoneal dialysis. Clin Nephrol 1990;34:131-135.
194. Harvey E, Secker D, Braj B, et al. The team approach to the management of children on chronic peritoneal dialysis. Adv Renal Replace Ther 1996;3:3-13.
195. Verrina E, et al. Prevention of peritonitis in children on peritoneal dialysis. Perit Dial Int 2000;20:625-630.
196. Hisano S, et al. Immune status of children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol 1992;6:179-181.
197. Warady B, Campoy S, Gross S, et al. Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. J Pediatr 1984;105:726-730.
198. Watson A, Vigneux A, Bannatyne R, et al. Peritonitis during continuous ambulatory peritoneal dialysis in children. CMAJ 1986;134:1019-1022.
199. Levy M, Balfe J. Optimal aproach to the prevention and treaetment of peritonitis in children undergoing continuous ambulatory and continuous cycling peritoneal dialysis. Semin Dial 1994;7:442-449.
200. Warady B, Schaefer F. Peritonitis. In: Warady B, Schaefer F, Fine R, et al., eds. Pediatric dialysis. Dordrecht: Kluwer Academic Publishers, 2004:393-413.
201. Watkins S, et al. Impact of flush-before-fill methodology on peritonitis rates in patients receiving automated peritoneal dialysis. J Am Soc Nephrol 1998;9:716A.
202. Kingwatanakul P, Warady B. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis. Adv Perit Dial 1997;13:280-283.
203. Oh J, et al. Nasal carriage of Staphylococcus aureus in families of children on peritoneal dialysis. Adv Perit Dial 2000;16:324-327.
204. Warady B, Schaefer F, Holloway M, et al. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int 2000;20:610-624.
205. Oh J, et al. Nasal mupirocin prophylaxis reduces the incidence of PD-related S. aureus infections in children: results of a double-blind, placebo-controlled multicenter trial. Perit Dial Int 2002; 22(Suppl 1):S74.
206. Auron A, Simon S, Andrews W, et al. Prevention of peritonitis in children receiving peritoneal dialysis. Pediatr Nephrol 2007;22:578-585.
207. Holloway M, et al. Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates. Perit Dial Int 2001;21:401-404.
208. Warady B, Feneberg R, Verrina E, et al. Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol 2007;18:2172-2179.
209. Schaefer F, Feneberg R, Aksu N, et al. Worldwide variation of dialysis-associated peritonitis in children. Kidney Int 2007;72:1374-1379.
210. Piraino B, Bailie G, Bernardini J, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005;25 : 107-131.
211. Warady B. Sclerosing encapsulating peritonitis: what approach should be taken with children? Perit Dial Int 2000;20:390-391.
212. Araki Y, Hataya H, Tanaka Y, et al. Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children. Perit Dial Int 2000;20:445-451.
213. Hoshii S, Honda M, Itami N, et al. Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol 2000;14:275-279.
214. Bourquelot P, Cussenot O, Cordy P, et al. Microsurgical creation and follow-up of arteriovenous fistulae for chronic haemodialysis in children. Pediatr Nephrol 1990;4:156-159.
215. Bourquelot P, Raynaud F, Pirozzi N. Microsurgery in children for creation of arteriovenous fistulas in renal and non-renal diseases. Ther Apher Dial 2003;7:498-503.
216. Goldstein S, Allsteadt A, Smith C, et al. Proactive monitoring of pediatric hemodialysis vascular access: effects of ultrasound dilution on thrombosis rates. Kidney Int 2002;62:272-275.
217. Goldstein S, Smith C, Currier H. Noninvasive interventions to decrease hospitalization and associated costs for pediatric patients receiving hemodialysis. J Am Soc Nephrol 2003;14:2127-2131.
218. Sheth R, Brandt M, Brewer E, et al. Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease. Kidney Int 2002;62:1864-1869.
219. Ramage I, Bailie A, Tyerman K, et al. Vascular access survival in children and young adults receiving long-term hemodialysis. Am J Kidney Dis 2005;45:708-714.
220. Goldstein S, Macierowski C, Jabs K. Hemodialysis catheter survival and complications in children and adolescents. Pediatr Nephrol 1997;11:74-77.
221. Sharma A, Zilleruelo G, Abitbol C, et al. Survival and complications of cuffed catheters in children on chronic hemodialysis. Pediatr Nephrol 1999;13:245-248.
222. Sheth R, Kale A, Brewer E, et al. Successful use of Tesio catheters in pediatric patients receiving chronic hemodialysis. Am J Kidney Dis 2001;38:553-559.
223. Memoli B. Cytokine production in haemodialysis. Blood Purif 1999; 17:149-158.
224. Memoli B, Marzano L, Bisesti V, et al. Hemodialysis-related lymphomononuclear release of interleukin-12 in patients with end-stage renal disease. J Am Soc Nephrol 1999;10:2171-2176.
225. Goldstein S, Currier H, Watters L, et al. Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 2003;143:653-657.
226. Goldstein S. Adequacy of dialysis in children: does small solute clearance really matter? Pediatr Nephrol 2004;19:1-5.
227. Smye S, Evans J, Will E, et al. Paediatric haemodialysis: estimation of treatment efficiency in the presence of urea rebound. Clin Phys Physiol Meas 1992;13:51-62.
228. Gotch F, Sargent J. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-534.
229. Evans J, Smye S, Brocklebank J. Mathematical modeling of haemodialysis in children. Pediatr Nephrol 1992;6:349-353.
230. Borah M, Schoenfeld P, Gotch F, et al. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978;14:491-500.
231. Grupe W, Harmon W, Spinozzi N. Protein and energy requirements in children receiving chronic hemodialysis. Kidney Int 1983;15: S6-S10.
232. Kaysen G, Chertow G, Adhikarla R, et al. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 2001;60:333-340.
233. Tom A, McCauley L, Bell L, et al. Growth during maintenance hemodialysis: impact of enhanced nutrition and clearance. J Pediatr 1999;134:464-471.
234. Goldstein S, Baronette S, Gambrell T, et al. nPCR assessment and IDPN treatment of malnutrition in pediatric hemodialysis patients. Pediatr Nephrol 2002;17:531-534.
235. Orellana P, Juarez-Congelosi M, Goldstein S. Intradialytic parenteral nutrition treatment and biochemical marker assessment for malnutrition in adolescent maintenance hemodialysis patients. J Ren Nutr 2005;15:312-317.
236. Goldstein S, Sorof J, Brewer E. Natural logarithmic estimages of Kt/V in the pediatric hemodialysis population. Am J Kidney Dis 1999;33:518-522.
237. Goldstein S. Hemodialysis in the pediatric patient: state of the art. Adv Renal Replace Ther 2001;8:173-179.
238. Goldstein S, Brewer E. Logarithmic extrapolation of a 15-minute postdialysis BUN to predict equilibrated BUN and calculate double-pool Kt/V in the pediatric hemodialysis population. Am J Kidney Dis 2000;36:98-104.
239. Goldstein S, Sorof J, Brewer E. Evaluation and prediction of urea rebound and equilibrated Kt/V in the pediatric hemodialysis population. Am J Kidney Dis 1999;34:49-54.
240. Sharma A, Espinosa P, Bell L, et al. Multicompartment urea kinetics in well-dialyzed children. Kidney Int 2000;58:2138-2146.
241. Marsenic O, Pavlicic D, Peco-Antic A, et al. Prediction of equilibrated urea in children on chronic hemodialysis. ASAIO J 2000;46:283-287.
242. Brem A, Lambert C, Hill C, et al. Clinical morbidity in pediatric dialysis patients: data from the Network 1 Clinical Indicator Project. Pediatr Nephrol 2001;16:854-857.
243. Goldstein S, Brem A, Warady B, et al. Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare Medicaid Services Clinical Performance Measures Project. Pediatr Nephrol 2006;21:1161-1166.
244. Locatelli F, Buoncristiani U, Canaud B, et al. Dialysis dose and frequency. Nephrol Dial Transplant 2005;20:285-296.
245. Perriatos A. Daily nocturnal home hemodialysis. Kidney Int 2004;65:1975-1986.
246. Fischbach M, Terzic J, Laugel V, et al. Daily online hemodiafiltration: a pilot trial in children. Nephrol Dial Transplant 2004;19:2360-2367.
247. Geary D, Piva E, Gajaria M, et al. Development of a nocturnal home hemodialysis (NHHD) program for children. Semin Dial 2004;17:115-117.
248. TM system in pediatric paatients receiving maintenance hemodialysis. Pediatr Nephrol 2007;23:129-135.
249. Sadowski R, Allred E, Jabs K. Sodium modeling ameliorates intradialytic and interdialytic symptoms in young hemodialysis patients. J Am Soc Nephrol 1993;4:1192-1198.
250. Steuer R, Leypoldt J, Cheung A, et al. Hematocrit as an indicator of blood volume and a predictor of intradialytic morbid events. ASAIO J 1994;40:M691-M696.
251. Steuer R, Leypoldt J, Cheung A, et al. Reducing symptoms during hemodialysis by continuously monitoring the hematocrit. Am J Kidney Dis 1996;27:525-532.
252. Jain S, Smith L, Brewer E, et al. Non-invasive intravascular monitoring in the pediatric hemodialysis population. Pediatr Nephrol 2001;16:15-18.
253. Michael M, Brewer E, Goldstein S. Blood volume monitoring to achieve target weight in pediatric hemodialysis patients. Pediatr Nephrol 2004;19:432-437.
254. Patel H, Goldstein S, Mahan J, et al. A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients. Clin J Am Soc Nephrol 2007;2:252-257.
255. Simmons J, Wilson C, Potter D, et al. Relation of calorie deficiency to growth failure in children on hemodialysis and the growth response to calorie supplementation. N Engl J Med 1971;285:653-656.
256. Conley S, Rose G, Robson A, et al. Effects of dietary intake and hemodialysis on protein turnover in uremic children. Kidney Int 1980;17:837-846.
257. Juarez-Congelosi M, Orellana P, Goldstein S. Normalized protein catabolic rate versus serum albumin as a nutrition status marker in pediatric patients receiving hemodialysis. J Ren Nutr 2007;17:269-274.
258. Zachwieja J, Duran M, Joles J, et al. Amino acid and carnitine supplementation in haemodialysed children. Pediatr Nephrol 1994;8:739-743.
259. Krause I, Shamir R, Davidovits M, et al. Intradialytic parenteral nutrition in malnourished children treated with hemodialysis. J Ren Nutr 2002;12:55-59.
260. Asayama K, Ito H, Nakahara C, et al. Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservativelly or with hemodialysis or transplantation. Pediatr Res 1984;18:783-788.
261. Van Gool S, Van Damme-Lombaerts R, Cobbaert C, et al. Lipid and lipoprotein abnormalities in children on hemodialysis and after renal transplantation. Transplant Proc 1991;23:1375-1377.
262. Gusmano R, Oleggini R, Perfumo F. Plasma carnitine concentrations and dyslipidemia in children on maintenance hemodialysis. J Pediatr 1981;99:429-432.
263. Gloggler A, Bulla M, Puchstein C, et al. Plasma and muscle carnitine in healthy and hemodialyzed children. Child Nephrol Urol 1988;9:277-282.
264. Gloggler A, Bulla M, Furst P. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children. Kidney Int 1989;27:S256-S258.
265. Sadowski R, et al. Acute hemodialysis of infants weighing less than five kilograms. Kidney Int 1994;45:903-906.
266. Eschbach J. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989;35:134-148.
267. McGonigle R, Boineau F, Beckman B, et al. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease. J Lab Clin Med 1985;105:449-458.
268. Meytes D, Bogin E, Ma A, et al. Effect of parathyroid hormone on erythropoiesis. J Clin Invest 1981;67:1263-1269.
269. Eschbach J, Korn D, Finch C. 14C cyanate as a tag for red cell survival in normal and uremic man. J Lab Clin Med 1977;89:823-828.
270. Muller-Wiefel D, Sinn H, Gilli G, et al. Hemolysis and blood loss in children with chronic renal failure. Clin Nephrol 1977;8:481-486.
271. Alexander S. Pediatric uses of recombinant human erythropoietin: the outlook in 1991. Am J Kidney Dis 1991;18:42-53.
272. Lerner G, Kale A, Warady B, et al. Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease. Pediatr Nephrol 2002;17:933-937.
273. De Palo T, Giordano M, Palumbo F, et al. Clinical experience with darbepoietin alfa (NESP) in children under going hemodialysis. Pediatr Nephrol 2004;19:337-340.
274. Scigalla P. Effect of recombinant human erythropoietin treatment on renal anemia and growth of children with end-stage renal disease. In: Gurland H, Moran J, Samtleben W, Scigalla P, Wieczorek L, eds. Erythropoietin in renal and non-renal anemias. Contributions to nephrology. Basel: Karger, 1991:201-211.
275. Kausz A, Watkins S, Hansen C, et al. Intraperitoneal erythropoietin in children on peritoneal dialysis: a study of pharmacokinetics and efficacy. Am J Kidney Dis 1999;34:651-656.
276. Reddingus R, Schroder C, Monnens L. Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis. Eur J Pediatr 1992;151:540-542.
277. Huang T, Lin C. Intraperitoneal recombinant human erythropoietin therapy: influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis. Am J Nephrol 1995;15:312-317.
278. Rao D, Shih M, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 1993;328:171-175.
279. Hymes L, Hawthorne S, Chavers B. Impaired response to recombinant human erythropoietin therapy in children with peritonitis. Dial Transplant 1994;23:462-463.
280. Bargman J, Nordfors L, Silverman E. The effect of in vivo erythropoietin on cytokine mRNA in CAPD patients. Adv Perit Dial 1994;10:129-134.
281. Stevens J, Winearls C. Serum from continuous ambulatory peritoneal dialysis patients with acute bacterial peritonitis inhibits in vitro erythroid colony formation. Am J Kidney Dis 1994;24:569-574.
282. Singh A, Szczech L, Tang K, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-2098.
283. Drueke T, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071-2084.
284. National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47:S1-S146.
285. National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007; 50:471-530.
286. Warady B, Ho M. Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol 2003;18:1055-1062.
287. Amaral S, Hwang W, Fivush B, et al. Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis. J Am Soc Nephrol 2006;17:2878-2885.
288. Chavers B, Roberts T, Herzog C, et al. Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients. Kidney Int 2004;65:266-273.
289. Warady B, Zobrist R, Wu J, et al. The Ferrlecit Pediatric Study Group. Sodium ferric gluconate complex therapy in anemic children on hemodialysis. Pediatr Nephrol 2005; 20:1320-1327.
290. Warady B, Zobrist R, Finan E. Ferrlecit Pediatric Study Group. Sodium ferric gluconate complex maintenance therapyin children on hemodialysis. Pediatr Nephrol 2006; 21:553-560.
291. Warady B, Seligman P, Dahl N. Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients. Clin J Am Soc Nephrol 2007;2:1140-1146.
292. Milman N. Iron absorption measured by whole body counting and the relation to marrow iron stores in chronic uremia. Clin Nephrol 1982;17:77-81.
293. Coyne D, Kapoian T, Suki W, et al. Ferric gluconate is highly efficacious in anemic hemodilaysis patients with high serum ferritin and low transferrin saturation: results of the dialysis patients' response to IV iron with elevated ferritin (DRIVE) study. J Am Soc Nephrol 2007;18:975-984.
294. Morgan H, Gautam M, Geary D. Maintenance intravenous iron therapy in pediatric hemodialysis patients. Pediatr Nephrol 2001;16:779-783.
295. Warady B, Kausz A, Lerner G, et al. Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol 2004;19:655-661.
296. Fudin R, Jaichenko J, Shostak A, et al. Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study. Nephron 1998;79:299-305.
297. St. Peter W, Obrador G, Roberts T, et al. Trends in intravenous iron use amoung dialysis patients in the United States (1994-2002). Am J Kidney Dis 2005;46:650-660.
298. Fishbane S, Ungureanu V, Maesaka J, et al. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 1996;28:529-534.
299. H'rl W. Iron therapy for renal anemia: how much needed, how much harmful? Pediatr Nephrol 2007;22:480-489.
300. Charytan C, Levin N, Al-Saloum M, et al. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. Am J Kidney Dis 2001;37:300-307.
301. Leijn E, Monnens L, Cornelissen E. Intravenous iron supplementation in children on hemodialysis. J Nephrol 2004;17:423-426.
302. Broyer M, Le Bihan C, Charbit M, et al. Long-term social outcome of children after kidney transplantation. Transplantation 2004;77:1033-1037.
303. Rosenkranz J, Reichwald-Klugger E, Oh J, et al. Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease. Pediatr Nephrol 2005;20:1288-1294.
304. Mahan J, Warady B. Consensus Committee. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol 2006;21:917-930.
305. Fine R, Kohaut E, Brown D, et al. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr 1994;124:374-382.
306. Fine R. Growth hormone treatment of children with chronic renal insufficiency, end-stage renal disease and following renal transplantation-update 1997. Pediatr Endocrinol 1997;10:361-370.
307. Warady B. New hormones in the therapeutic arsenal of chronic renal failure: growth hormone and erythropoietin. Pediatr Clin North Am 1995;42:1551-1577.
308. Warady B. Growth retardation in children with chronic renal insufficiency. J Am Soc Nephrol 1998;9:S85-S89.
309. Fine R, Ho M, Tejani A, et al. Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 2003;142:539-545.
310. Tonshoff B, et al. Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 1990;116:561-566.
311. Schaefer F, Wuhl E, Haffner D, et al. Stimulation of growth by recombinant human growth hormone in children undergoing peritoneal or hemodialysis treatment. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Adv Perit Dial 1994;10:321-326.
312. Haffner D, Schaefer F, Nissel R, et al. Effect of growth hormone treatment on the adult height of children with chronic renal failure. N Engl J Med 2000;343:923-930.
313. Vimalachandra D, Craig J, Cowell C, etal. Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. J Pediatr 2001;139:560-567.
314. Tonshoff B, Mehls O. Growth retardation in children with chronic renal insufficiency: current aspects of pathophysiology and treatment. J Nephrol 1995;8:133-142.
315. Wuhl E, Haffner D, Nissel R, et al. Short dialyzed children repond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 1996;10:294-298.
316. Klaus G, Watson A, Edefonti A, et al. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 2006;21:151-159.
317. Salusky I, Coburn J, Brill J, et al. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 1988;33:975-982.
318. Delmez J, Tindira C, Grooms P, et al. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest 1989;83:1349-1355.
319. Szabo A, Merke J, Beier E, et al. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 1989;35:1049-1056.
320. Sprague S, Lerma E, McCormmick D, et al. Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. Am J Kidney Dis 2001;38:S51-S56.
321. Andress D. Intravenous versus oral vitamin D therapy in dialysis patients: what is the question? Am J Kidney Dis 2001;38:S41-S44.
322. Greenbaum L, Benador N, Goldstein S, et al. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis. Am J Kidney Dis 2007;49:814-823.
323. Sprague S, Llach F, Amdahl M, et al. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int 2003;63:1483-1490.
324. Seeherunvong W, Nwobi O, Abitbol C, et al. Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol 2006;21:1434-1439.
325. Strippoli G, Tong A, Palmer S, et al. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev 2006;18:CD006254.
326. Sedman A, Wilkening G, Warady B, etal. Encephalopathy in childhood secondary to aluminum toxicity. J Pediatr 1984;105:836-838.
327. Salusky I, Coburn J, Foley J, et al. Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis. J Pediatr 1986;108:767-770.
328. Mactier R, Van Stone J, Cox A, et al. Calcium carbonate is an effective phosphate binder when dialysate calcium concentration is adjusted to control hypercalcemia. Clin Nephrol 1987;28:222-226.
329. Mai M, Emmett M, Sheikh M, et al. Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 1989;36:690-695.
330. Amin N. The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure. Nephrol Dial Transplant 2002;17:340-345.
331. Salusky I, Goodman W, Sahney S, etal. Sevelamercontrolsparathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol 2005;16:2501-2508.
332. Goodman W, Goldin J, Kuizon B, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
333. Parekh R, Carroll C, Wolfe R, et al. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 2002;141:191-197.
334. Chavers B, Li S, Collins A, et al. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 2002;62:648-653.
335. Chertow G, Burke S, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.
336. Pieper A, Haffner D, Hoppe B, et al. A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis 2006;47:625-635.
337. Slatopolsky E, Weerts C, Lopez-Hilker S, et al. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 1986;315:157-161.
338. Osorio A, Seidel F, Warady B. Hypercalcemia and pancreatitis in a child with adynamic bone disease. Pediatr Nephrol 1997;11:223-225.
339. National Kidney Foundation K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;22:S1-S290.
340. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-576.
341. Zucchelli P, Zuccala A. Control of blood pressure in patients on haemodialysis. In: Cameron S, Davison A, Grunfeld J, et al., eds. Oxford textbook of clinical nephrology. Oxford: Oxford University Press, 1992:1458-1467.
342. Zucchelli P, Santoro A, Zuccala A. Genesis and control of hypertension in hemodialysis patients. Semin Nephrol 1988;8:163-168.
343. Converse RJ, Jacobsen T, Toto R, et al. Sympathetic over activity in patients with chronic renal failure. N Engl J Med 1992;327:1912-1918.
344. Mitsnefes M, Stablein D. Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 2005;45:309-315.
345. Van DeVoorde R, Barletta G, Chand D, et al. Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol 2007;22:547-553.
346. Gerson A, Butler R, Moxey-Mims M, et al. Neurocognitive outcomes in children with chronic kidney disease: current findings and contemporary endeavors. Ment Retard Dev Disabil Res 2006;12:208-215.
347. Polinsky M, Kaiser B, Stover J, et al. Neurologic development of children with severe chronic renal failure from infancy. Pediatr Nephrol 1987;1:157-165.
348. Warady B. Neurodevelopment of infants with end-stage renal disease: is it improving? Pediatr Transplant 2002;6:5-7.
349. Ledermann S, Scanes M, Fernando O, et al. Long-term outcome of peritoneal dialysis in infants. J Pediatr 2000;136:24-29.
350. Madden S, Ledermann S, Guerrero-Blanco M, et al. Cognitive and psychosocial outcome of infants dialysed in infancy. Child Care Health Dev 2003;29:55-61.
351. Warady B, Belden B, Kohaut E. Neurodevelopmental outcome of children initiating dialysis in early infancy. Pediatr Nephrol 1997;13:759-765.
352. Glenn C, Astley S, Watkins S. Dialysis-associated seizures in children and adolescents. Pediatr Nephrol 1992;6:182-186.
353. McDonald S, Craig J. Long-term survival of children with end-stage renal disease. N Engl J Med 2004;350:2654-2662.
354. Brownbridge G, Fielding D. Psychosocial adjustment and adherence to dialysis treatment regimes. Pediatr Nephrol 1994;8:744-749.
355. Fukunishi I, Honda M. School adjustment of children with end-stage renal disease. Pediatr Nephrol 1995;9:553-557.
356. Fukunishi I, Kudo H. Psychiatric problems of pediatric end-stage renal failure. Gen Hosp Psychiatry 1995;17:32-36.
357. Brownbridge G, Fielding D. Psychosocial adjustment to end-stage renal failure: comparing haemodialysis, continuous ambulatory peritoneal dialysis and transplantation. Pediatr Nephrol 1991;5:612-662.
358. Rosenkranz J, Bonzel K, Bulla M, et al. Psychosocial adaptation of children and adolescents with chronic renal failure. Pediatr Nephrol 1992;6:459-463.
359. Goldstein S, Graham N, Burwinkle T, et al. Health-related quality of life in pediatric patients with ESRD. Pediatr Nephrol 2006;21:846-850.
360. McKenna A, Keating L, Vigneux A, etal. Quality of life in children with chronic kidney disease-patient and caregiver assessments. Nephrol Dial Transplant 2006;21:1899-1905.
361. Reynolds J, Morton M, Garralda M, et al. Psychosocial adjustment of adult survivors of a paediatric dialysis and transplant programme. Arch Dis Child 1993;68:104-110.
362. Morton M, Reynolds J, Garralda M, et al. Psychiatric adjustment in end-stage renal disease: a follow up study of former paediatric patients. J Psychosom Res 1994;38:293-303.
363. Henning P, Tomlinson L, Rigden S, et al. Long term outcome of treatment ofend stage renal failure. Arch Dis Child 1988;63:35-40.
364. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). 2006 Annual report. 2007.